Jun 2, 2026 08:31AM
Jun 2, 2026 08:30AM
May 28, 2026 04:30PM
May 14, 2026 08:30AM
May 7, 2026 05:00PM
May 6, 2026 04:05PM
Apr 29, 2026 04:30PM Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026
Mar 31, 2026 08:30AM
Mar 31, 2026 08:30AM
Mar 23, 2026 08:32AM
Mar 23, 2026 08:30AM
Feb 26, 2026 04:30PM
Feb 23, 2026 04:05PM
Feb 18, 2026 08:30AM Tarsus Pharmaceuticals adds former Allergan CEO David Pyott to board
Feb 18, 2026 08:30AM
Feb 17, 2026 04:30PM
Nov 24, 2025 04:30PM
Nov 5, 2025 05:05PM
Nov 4, 2025 04:05PM
Oct 28, 2025 05:00PM
Aug 27, 2025 05:00PM Tarsus to Participate in Upcoming Investor Conferences
Aug 6, 2025 04:05PM
Jul 31, 2025 07:00AM
Jul 30, 2025 05:00PM
May 29, 2025 05:00PM
May 27, 2025 06:06AM
May 8, 2025 05:00PM
May 5, 2025 07:39AM Elanco Animal Health (ELAN) sells certain royalties and commercial milestones associated with XDEMVY to Blackstone Life Sciences and Blackstone Credit & Insurance for $295M Cash
May 5, 2025 06:27AM
May 1, 2025 04:05PM
Apr 24, 2025 05:00PM
Apr 22, 2025 08:31AM
Apr 21, 2025 04:05PM
Mar 12, 2025 09:49PM
Mar 12, 2025 04:13PM Tarsus Pharmaceuticals (TARS) Announces Proposed $100M Public Offering
Mar 12, 2025 04:12PM
Mar 6, 2025 05:00PM
Feb 25, 2025 07:00AM
Feb 20, 2025 05:00PM
Jan 30, 2025 05:00PM
Jan 15, 2025 05:04AM
Jan 13, 2025 08:37AM Tarsus Pharmaceuticals (TARS) Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care
Jan 13, 2025 08:30AM
Nov 13, 2024 04:05PM
Nov 13, 2024 08:30AM
Nov 13, 2024 08:30AM
Nov 6, 2024 04:30PM
Nov 5, 2024 08:30AM
Nov 5, 2024 08:30AM Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer
Oct 17, 2024 08:30AM

322,937 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All